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Background and purpose: Epidemiological studies have associated increased dietary 
intake of antioxidants (vitamin C, E, and β-carotene) in preventing and decreasing the extent 
of ischemic brain injury. The effect of vitamin C supplementation on functional recovery after 
stroke has not been studied. 
Method: In this retrospective, case-control study of 23 patients with ischemic stroke taking 
vitamin C were identiﬁ  ed and matched for age, sex, onset to admission, and admission total 
functional independence measure (TFIM) with 23 patients with ischemic stroke not taking 
Vitamin C supplementation. Vitamin C 1000 mg daily was prescribed on admission to our unit 
mainly to patients who were undernourished (deﬁ  ned as signiﬁ  cant weight loss and/or 90% or 
less ideal body weight for age and sex) and those with pressure sores. The outcome measures 
were: change in the TFIM, FIM-Cognition (FIM-Cog), and FIM-Motor sub-scores, discharge 
disposition, and length of stay (LOS). 
Results: The change in TFIM (20 ± 13 standard deviation [SD] vs. 26 ± 6, p = 0.20), FIM-Cog 
(3 ± 3 SD vs. 4 ± 5, p = 0.41), FIM-Motor (15 ± 11 SD vs. 20 ± 13, p = 0.21) sub-scores were 
less in the vitamin C treated group, but these differences did not reach statistical signiﬁ  cance. 
Similarly, no signiﬁ  cant differences were found in LOS (21 ± 9 SD vs. 23 ± 9, p = 0.59), and 
discharge disposition (home/institution) (9/10 vs. 13/9, p = 0.60) between the vitamin C and 
the control groups.
Conclusion: This study suggests vitamin C supplementation did not enhance functional recovery 
in undernourished ischemic stroke patients. 
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Introduction
Epidemiological studies show that diets high in fruits and vegetables are associated 
with lower risk of cardiovascular disease, stroke, and cancer, and with increased 
longevity (Keli et al 1996; Joshipura et al 1999; Voko et al 2003; Fung et al 2004). 
Whether these protective effects are directly attributable to vitamins C or E or other 
food constituents is not known. 
Cerebral ischemia results in vascular (endothelial) damage, and tissue injury 
(infarction). Tissue injury in the acute phase generates increase production of oxy-
gen (O2
–) radical, which in turn triggers necrosis in the acute phase, inﬂ  ammatory 
responses in the subacute phase, and apoptosis in the chronic phase. This oxidative 
stress increases the permeability of the blood-brain barrier leading to edema, and 
tends to increase lesion volume and neurological impairment in stroke (Leinonen 
et al 2000).
Cherubini and colleagues (2000), Gariballa and colleagues (2002), and Sanchez-
Moreno and colleagues (2004), in their respective studies have shown that the serum Clinical Interventions in Aging 2007:2(1) 148
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levels of most of the antioxidants (including vitamin C lev-
els) are reduced immediately after an acute ischemic stroke 
compared with controls, presumably as a consequence of 
increased oxidative stress. Inﬂ  ammatory markers (C-reactive 
protein, intercellular adhesion molecule-1, monocyte chemo-
tactic protein-1) are increased simultaneously. Intervention 
studies with vitamin C have shown no change in markers of 
oxidation or clinical beneﬁ  t in chronic diseases particularly 
diabetes mellitus (Padayatty et al 2003). Schutte and col-
leagues (2004), studied the markers of vascular function 
in 31 young healthy male adults, who were administered a 
daily dosage of 1000 mg vitamin C, 800 mg vitamin E, and 
10 mg folate. Beneﬁ  cial decreases in diastolic blood pres-
sure due to increase in arterial compliance after 12 weeks 
of vitamin supplementation was noted, while no statistically 
signiﬁ  cant changes were observed with other cardiovascular 
variables such as systolic blood pressure, stroke volume, 
heart rate, cardiac output, vascular resistance, and arterial 
compliance. 
In contrast to the epidemiological data on diet and stroke 
incidence and severity, and clinical intervention studies in the 
acute phase, no prior studies have addressed the effective-
ness of vitamin C supplementation on functional recovery in 
patients undergoing rehabilitation after an ischemic stroke. 
Method
Patients 
Of the stroke patients admitted to our designated acute stroke 
rehabilitation unit over a 12-month period, 23 recovering 
ischemic stroke patients on vitamin C were matched to 23 
recovering ischemic stroke patients not on vitamin C (con-
trol). The inclusion criteria were: ﬁ  rst ischemic stroke event, 
and neuroimaging (computed tomography and/or magnetic 
resonance imaging) showing ischemic lesion corresponding 
to the clinical signs and symptoms. The exclusion criteria 
were: hemorrhagic stroke and recurrent ischemic stroke. 
Patients were matched for age; sex, onset-to-admission, and 
admission total functional independence measure (TFIM), 
which are factors known to inﬂ  uence functional motor re-
covery. The physician and the rehabilitation team members 
prospectively recorded the data in a computerized stroke 
database. 
Intervention(s) 
Ischemic stroke patients who were undernourished (deﬁ  ned 
as signiﬁ  cant weight loss, and/or 90% or less ideal body 
weight for age and sex, and an admission serum albumin 
<3.4 gm/dl) and/or had the presence of pressure sores were 
administered 1000 mg of vitamin C daily as part of its 
treatment protocol. Our institution’s Institutional Review 
Board approval was not obtained because administration of 
vitamin C for undernourished patients and/or presence of 
pressure sore are considered a part of the standard of care 
at our institution. 
Quantiﬁ  able outcome measures 
The primary outcome measures were: change in the TFIM 
score, FIM-Cognition (FIM-Cog), and FIM-Motor sub-
scores. The secondary outcome measures were: discharge 
disposition (home discharge vs. long-term care facility) and 
length of stay (LOS). 
The Functional Independence Measure (FIM™) tool 
was used to measure the degree of disability as well as 
the progress the patients made through medical rehabilita-
tion programs (Granger 1998). The FIM scale is a reliable 
(Stineman et al 1996) and a valid functional independence 
measure (Stineman and Maislin 2000). The FIM has become 
the standard functional assessment measures of self-care and 
mobility in rehabilitation medicine in the United States. The 
FIM is an 18-item ordinal scale scored from 1 to 7. A FIM 
item score of seven is categorized as “complete indepen-
dence”, while a score of one is “total assist”. The possible 
total score ranges from 18 (maximum level of dependence) 
to 126 (highest level of independence). Stroke rehabilitation 
team members who are FIM-certiﬁ  ed scored the admission 
and discharge total FIM score.
Data analysis
Groups were compared for demographic data and outcome 
measures. Continuous and nominal variables between the 
two groups were analyzed using Student’s t-test and Chi-
square analyses. 
A p < 0.05 signiﬁ  cance level was used for all analyses. 
The statistical analysis was carried out by commercial statisti-
cal software package Stat View (version 5.0.1 SAS Institute 
Inc. Cary, NC 27513; 1992 to 1998). Subgroup analysis was 
done by paired t-test in Excel.
Results
Table 1 presents the demographics of our study sample 
(n = 46) for the 2 groups based on presence or absence of 
vitamin C supplementation intake. The mean age (±SD) of 
our patients was 76 ± 11 years (range 49–89 years). The 
male/female ratio was 26/20. The onset of stroke to admis-
sion to our unit was 11 ± 6 days. The admission TFIM score 
was 41 ± 18. The average LOS in our study population was Clinical Interventions in Aging 2007:2(1) 149
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19 ± 11 days. The vitamin C treated (n = 23) versus control 
(n = 23) group were well matched for: age (p = 0.84), M/F 
ratio (p = 1.0), onset-to-admission (p = 0.38), prior level 
of physical independence (p = 1.0), and admission TFIM 
(p = 0.99) (Table 1). There were 15 patients in the vitamin 
C group and only 1 patient in the control group (p = 0.0001) 
who had pressure sores. 
The changes in TFIM (p = 0.20), FIM-Cog (p = 0.41), 
and FIM-Motor (p = 0.21) sub-scores were consistently less 
in the Vitamin C treated group compared with the controls 
but the differences did not reach statistical signiﬁ  cance 
(Table 2). Similarly, no signiﬁ  cant differences were found 
between the 2 groups for LOS (p = 0.59), and discharge 
disposition to home/or institution (p = 0.60). In view of the 
lack of difference between the primary and secondary out-
come measures between the 2 groups, a post-hoc analysis 
between the two groups for the primary outcome variables 
in the undernourished ischemic stroke patients (n = 8) versus 
their cognate controls (n = 8) was undertaken. The p value 
(0.07, but power <0.8) failed to reach pre-set levels for 
statistical signiﬁ  cance (p < 0.05), but possibly suggested 
that individual displaying evidence of malnourishment had 
worse outcomes.
Discussion
In this retrospective, case-study, administration of vitamin 
C supplementation did not improve functional recovery in 
ischemic stroke patients. However, ischemic stroke patients 
Table 1 Baseline variables between the two patient groups based on the presence or absence of vitamin C intake (Mean ± SD)
Grouping variables  Total population   Vitamin C   Control  P-value
  (n = 46)  (n = 23)  (n = 23) 
Age in yearst  76 ± 11  76 ± 11  77 ± 11  0.84
Sex (M:F)c 26:20  13:10  13:10  1.0
Onset to admission in dayst  11 ± 6  12 ± 7  11 ± 5  0.38
Stroke type:c       0.14
 Ischemic       
    Thrombotic  33 (71%)  19 (82%)  14 (61%) 
    Embolic  10 (22%)  02 (9%)  08 (35%) 
    Carotid occlusion with stroke  03 (7%)  02 (9%)  01 (4%) 
Risk factorsc
  Hypertension  35 (76%)  16 (70%)  19 (83%)  0.29
  Diabetes mellitus  17 (37%)  11 (48%)  06 (26%)  0.12
  Hyperlipidemia  11 (24%)  06 (26%)  05 (22%)  0.72
  Myocardial infarction  06 (13%)  01 (4%)  05 (22%)  0.06
  Congestive cardiac failure  10 (22%)  02 (9%)  08 (35%)  0.47
 Atrial  ﬁ  brillation  09 (20%)  02 (9%)  07 (30%)  0.03
  Osteoarthritis  08 (17%)  05 (22%)  03 (13%)  0.43
Prior level of independence        1.0
  Independent  36 (78%)  18 (78%)  18 (78%) 
  Independent with assistive device  08 (17%)  04 (17%)  04 (17%) 
  Need physical assistance  02 (4%)  01 (4%)  01 (4%) 
Pressure sorec  16 (35%)  15 (65%)  01 (4%)  0.0001
Stroke severity:
 MMSEm  15 ± 11  16 ± 10  14 ± 12  0.70
 Visual  ﬁ  eld:c       0.12
  Normal  28 (61%)  12 (52%)  16 (70%) 
  Left homonymous hemianopsia  04 (9%)  04 (17%)  00 (%) 
  Right homonymous hemianopsia  07 (15%)  02 (9%)  05 (22%) 
  Left visual neglect  04 (9%)  03 (13%)  01 (4%) 
  Right visual neglect   03 (6%)  02 (9%)  01 (4%) 
 UE  MSSt (n = 16, n = 17) (range: 0–66)  29 ± 26  25 ± 27  33 ± 25  0.37
 LE  MSSt (range: 0–34)  14 ± 10  14 ± 11  14 ± 9  0.95
 Limb  placementt  6 ± 4  6 ± 4  6 ± 3  0.71
TFIM Score—Admissiont  41 ± 18  41 ± 18  41 ± 18  0.99
Note: t Student’s t-test; c Chi-square; m Mann–Whitney U test. 
Abbreviations: LE, lower extremity; MMSE, Mini-Mental State Examination; MSS, Motor Status Score; SD, standard deviation; TFIM, total functional independence measure; 
UE, upper extremity. Clinical Interventions in Aging 2007:2(1) 150
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who had pressure sores and were assigned to the vitamin C 
group had a much lesser change in the functional outcome 
scores compared with those assigned to the control group. 
We are unable to explain the results of these findings. 
Moreover, the ﬁ  nding of this study is in agreement with the 
result of other randomized control trials of vitamin C, E, 
and β-carotene supplementations in high-risk patients with 
occlusive arterial disease or diabetes. In these cases vitamin 
C supplementation had no effect on the incidence of any type 
of vascular disease (fatal and nonfatal myocardial infarction 
and stroke), nor did it produce any signiﬁ  cant reductions in 
the 5-year mortality. This result was found despite signiﬁ  cant 
increases in the plasma concentrations of these vitamins 
(HPSCG 2002). 
Confounding factors which may have been responsible 
for this lack of difference between the 2 groups associated 
with our study include: 1) Inappropriate timing of the vita-
min C administration. Most of the oxidative stress damage 
is said to occur in the initial 24–48 hours post-stroke (Keli 
et al 1996), when one would expect a better response to 
antioxidants administration. Our patients were admitted 
11 ± 6 days post-stroke. 2) Inappropriate dosing of vitamin C. 
It is possible that the dose of vitamin C was not high enough 
to exert its desired effect (Hathcock et al 2005). 3) Vitamin 
C may be a weak antioxidant in vivo, and its antioxidant 
effect may be more effective when given together with other 
antioxidant vitamins, as typically occurs in the diet (Willett 
and Stampfer 2001), rather than when taken by itself alone. 
4) The pro-oxidant effect of vitamin C could be a mitigat-
ing factor. In vitro studies have shown that vitamin C has 
the ability to act as a pro-oxidant by chemically catalyzing 
hydroxyl-radical formation in the presence of metal, such as 
iron (Guo et al 2002; Bailey et al 2006). Recent double-blind 
placebo controlled in vivo study of 22 patients undergoing 
vascular surgery for elective abdominal aortic aneurysm, 
and by-pass repair found vitamin C prophylaxis to promote 
oxidative lipid damage during surgical ischemia-reperfu-
sion (Podmore et al 1998). 5) Though our groups were 
(demographically and entry FIM) case-control, the vitamin 
C group was predominantly undernourished compared with 
the nonvitamin C group. 
This study is limited by three considerations: i) the 
retrospective analysis of computerized stroke patient data, 
which inherently constrains the ability to randomize the 
patient population; ii) the small sample size, which limits 
the types of conclusions that can be tested statistically, eg, 
because of the potential for Type II statistical errors, and; 
iii) the subjects though matched for variables known to 
inﬂ  uence functional outcomes, they could not be matched 
for nutritional status or for pressure sores without changing 
the standard of care at our hospital. While this does place 
some constraints on the potential to draw conclusions from 
our data, it is possible that the observed trend toward worse 
outcomes for vitamin C-treated patients might be at least 
partially independent of the pre-entrance status of these 
individual. This is consistent with the recently published 
study showing a detrimental effect of vitamin C in surgi-
cal patients noted above (Podmore et al 1998). Finally, our 
data suggest consideration, such as matching for nutritional 
status should be considered for future prospective, random-
ized trials.
Conclusion
This study suggests that vitamin C supplementation in 1 gm 
dosage has no impact on motor recovery after ischemic 
stroke. Retrospective subgroup analysis of a small sub-
population (n = 8) suggests a possible negative association 
between undernourished ischemic stroke patients, vitamin C 
Table 2 Secondary outcome measures between the two patient groups based on presence or absence of vitamin C intake 
(Mean ± SD)
Grouping variables  Vitamin C (n = 23)  Control (n = 23)  p-value
Change in UDS TFIM Scoret  20 ± 13   26 ± 6  0.20
Change in UDS Cog-FIM Scoret    3 ± 3     4 ± 5  0.41
Change in UDS Motor-FIM Scoret  15 ± 11   20 ± 13  0.21
Length of Stay (LOS in days)t  21 ± 9  23 ± 9  0.59
Healed pressure sorec  05 (33%)  00 (%)  0.48
Discharge disposition:c     0.60
 Home  09  (39%)  13  (57%) 
  Skilled nursing facility  10 (43%)  09 (39%) 
  Acute hospital  03 (13%)  01 (4%) 
Note: t Student’s t-test; c Chi-square.
Abbreviations: FIM, Functional Independence Measure; LOS, length of stay; UDS, uniﬁ  ed data set.Clinical Interventions in Aging 2007:2(1) 151
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treatment, or the combination of these factors in a rehabilita-
tion population.
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